Abstract -To determine if there is an increase in the risk of seizure activity when patients experience recurrent alcohol detoxification, the histories of 360 alcoholics who had at least two admissions for alcohol detoxification, between November 1987 and August 1992, were reviewed retrospectively. All subjects were treated with tapering doses of chlordiazepoxide as required, to control symptoms/signs of alcohol withdrawal. Subjects with a seizure history were prophylactically treated with tapering doses of chlordiazepoxide. No seizures were observed during detoxification in any of these subjects. In this group of readmitted subjects, there was no correlation between self-reported duration of alcohol consumption or average daily intake of alcohol. A significant correlation was observed between seizure history and number of detoxification admissions and neurological admissions, but not for other medical/surgical admissions, nor for admissions for rehabilitation At the time of initial admission, laboratory parameters did not distinguish those subjects with seizures from those without. At the time of readmission, mean corpuscular volume and gamma-glutamyl transpeptidase, both markers of alcohol consumption, were higher in the group with seizures.
INTRODUCTION
In the early 1950s, Isabell etal. (1955) fed alcohol to 10 incarcerated males with a past history of morphine dependence. Only two subjects developed seizures following abrupt withdrawal of alcohol. The occurrence of seizures did not correlate with either the duration of, or with average daily, alcohol consumption. These data need to be interpreted cautiously, due to the small sample size and the atypical patient group, but suggest that factors in addition to the total amount of alcohol consumed were necessary for seizures to become manifest.
In a larger and more representative sample, an increase in new-onset seizures in alcoholics, which correlated with self-reported alcohol consumption, was observed (Ng et aL, 1988) . We also observed a correlation between self-reported average daily alcohol consumption and seizure prevalence, but the correlation was not as strong as that with the number of inpatient detoxification admissions (Lechtenberg and Worner, 1992) .
In 1953, Victor and Adams studied 88 alcoholics who developed seizures while undergoing detoxification and for whom there was detailed clinical information. They concluded that withdrawal of alcohol was responsible for the generation of seizures. Subsequently, Victor and Brausch (1967) concluded that abrupt withdrawal of alcohol following a period of chronic abuse was the most significant factor in precipitating seizures. The association of detoxification admissions and seizure histories has been confirmed (Ballenger and Post, 1978; Brown et aL, 1988) . One explanation for this correlation is a kindling effect in the alcoholic brain, which eventually results in clinically apparent seizures (Reynolds, 1989; McCown and Breese, 1990) . That detoxification itself is specifically related to the seizure prevalence is suggested by the lack of correlation between the incidence or prevalence of seizures and the duration of alcoholism (Isabell et aL, 1955; Lechtenberg and Worner, 1990) . Seizure histories are more commonly reported by patients with relatively short histories of alcoholism, but with several detoxification admissions, than by patients with long histories of alcoholism and only one or two detoxification admissions (Lechtenberg and Worner, 1990 ).
We recently observed that inpatient detoxification correlated more strongly with seizures than non-detoxification admissions (Lechtenberg and Worner, 1990) . Booth and Blow (1993) , in a retrospective analysis of admission records of 6818 alcoholics readmitted to 172 Veterans Affairs Medical Centers, reported a correlation between both detoxification and non-detoxification admissions and seizure prevalence. Limitations of their study were the lack of female alcoholics, lack of detailed information on alcohol use and other evidence of co-morbidity. The relation between admissions for neurological problems as compared to medical/surgical admissions was also not evaluated. This retrospective review of alcoholics readmitted to the same institution, with the same treatment staff, was done in order to address these issues.
METHODS
Patients admitted to the alcohol detoxification unit of The Long Island College Hospital between November 1987 and August 1992 were included. Criteria for patient selection and exclusion were previously described (Lechtenberg and Worner, 1990) .
Acquisition of history
An alcohol and drug history, obtained from the patient at the time of each admission, included histories of prior detoxifications and unrelated hospitalizations. Additional information was retrieved from hospital records. Drinking history was described in terms of the age at which alcohol consumption began, the number of years of alcoholism endured and the types and quantities of beverages routinely consumed. Daily amounts (in g) of ethanol consumed were calculated by equating 4 ounces of wine with 11.5 g of ethanol, 12 ounces of beer with 12.6 g and 1 ounce of distilled spirits with 10 g. Seizure histories were based on reports from the patients, family members and prior medical records. Neurological consultation was requested at the time of admission for all persons with a new onset seizure.
Drug use was determined from patient reports, toxicological studies on urine obtained at the time of admission and from chart reviews.
Treatment regimen
All patients admitted for detoxification received thiamine as a 100 mg intramuscular bolus on the day of admission. Chlordiazepoxide was adminis- 39.6 ± 9.4 24.0 ± 14.7 316 ± 195 *Mean ± SD. No significant differences between the two groups of subjects were observed.
tered orally at a dose dictated by the patient's signs and symptoms of alcohol withdrawal. The most tremulous and agitated patients were given as much as 50 mg of chlordiazepoxide hourly until their agitation abated. All patients with a past history of seizures were treated with a tapering dose of chlordiazepoxide, using the following oral regimen: 25 mg every 6h on day 1, 25 mg every 8 h on day 2, 25 mg every 12 h on day 3 and 25 mg once on day 4. Additional medication was administered if signs or symptoms of alcohol withdrawal were manifest.
Diagnostic testing
On the morning following admission, blood obtained by venipuncture was sent to the hospital laboratory for measurement of complete blood count, prothrombin time and a chemistry profile. Observed urine for toxicology was obtained at the time of admission and sent to the hospital laboratory. All tests were performed by standard laboratory techniques. Breath alcohol analysis was done on admission.
Data analysis
Student's /-tests, discriminant function analyses and regression analyses were performed where appropriate, with the significance level for probability of the null hypothesis set to 0.05. Statistical work was performed by an NCSS 5.02 program run on an IBM-PC computer (Hintze, 1989) .
RESULTS
As shown in Table 1 , on initial admission, there were no differences in age or self-reports of alcohol consumption. Approximately 20% of both males and females reported seizures at the time of the initial admission. As shown in The results in Table 3 show that, at the time of the first admission to our facility, there was a significant difference in the number of prior admissions both for neurological diseases and for detoxification done at other institutions. By contrast, there was no significant difference in the history of head trauma or the number of rehabilitation, medical or surgical admissions.
Between the time of the index admission to our facility and the readmission, the number of patients reporting seizures increased from 68 to 101. The mean interval (not statistically significant) between admissions for those without a seizure history was 8.5 months versus 7.3 months for those with a seizure history. Of the initial 68 subjects reporting seizures, 55 were male. At the time of readmission, 85 of the 101 subjects reporting seizures were male (data not shown). On readmission to our facility, there was again a significant difference between those with a positive seizure history compared with those without such a history, both in the number of detoxification admissions and admissions for neurological problems (Table 4) . It should also be noted that, at the time of the second admission, there was no significant difference between the groups in the admission rate for rehabilitation services or for other medical or surgical problems. All of these results are based on self-reports of hospital admissions. It is possible that admissions to facilities other than ours were not reported, resulting in an under-reporting of hospitalizations. Whenever possible, the clinical history was verified by a family member, close friend or prior clinical records. Admissions to our facility were corroborated by a review of the clinical record. Although it is possible that some admissions were filed in separate clinical charts, this is extremely unlikely. Shown in Table 5 are the results of laboratory tests at the time of readmission. In contrast to the normal results observed at the time of the first admission, on readmission, there were significant elevations of GGTP, alkaline phosphatase and MCV in the group with, compared to the group without, seizures. One can only speculate on the elevations of these laboratory parameters in the seizure-positive group. Although blood levels of phenytoin and phenobarbital at the time of admission were usually subtherapeutic in those persons who had reported taking such medications, it is possible that enough medication was consumed to induce GGTP. Alternatively, in view of elevations of all transaminases, these increases may represent a predisposition to liver disease in this seizure-prone alcoholic subset.
DISCUSSION
The present results confirm our previous observations Worner, 1991, 1992) and those of Booth and Blow (1993) that there is an increased number of detoxification admissions in those persons with an underlying seizure disorder. The conclusions of these studies, that seizures are also correlated with total number of non-detoxification admissions, is likewise confirmed. The results of these studies are further extended in the current study by the observation that admissions for neurologically-related problems are significantly correlated to seizure history, whereas admissions for other medical/surgical problems are not.
In contrast with our previous report, where all admitted subjects were evaluated, in this subgroup of readmitted subjects there is no correlation between average daily alcohol consumption and seizure history, either at the time of initial admission or at the time of readmission. This lack of correlation may be explained, in part, by the observation that this group of readmitted subjects had an overall higher self-reported daily alcohol intake, as compared with the previously reported group. This higher intake occurred both for the seizure-history-positive as well as for the group without a seizure history. As previously reported (Lechtenberg and Worner, 1990 , 1991 , 1992 , we again show no relationship between the seizure history and years of alcohol consumption either at the time of initial admission or at the time of readmission. These results are at variance with those of Ballenger and Post (1978) .
Although previous studies have addressed comorbidity in persons with seizures unrelated to alcohol, no studies have addressed co-morbidities in alcoholics presenting with new onset seizures. One way to assess co-morbidity is to evaluate laboratory parameters at the time of admission. In this group of subjects who were readmitted at least once, a wide spectrum of laboratory parameters at the time of initial admission did not distinguish between those subjects with seizures and those without. Indeed, blood glucose, haematocrit and WBC count were remarkably normal in both groups. Likewise, parameters of hepatic function (albumin, ALT, alkaline phosphatase and bilirubin) were also remarkably normal in both groups. Thus, none of these laboratory parameters appears to distinguish future seizure episodes in a given patient. Several factors are known to elevate GGTP. These include underlying liver disease, pancreatitis, some types of renal disease, medications such as phenobarbital or phenytoin, and enzyme induction resulting from chronic consumption of alcohol. In the present series, the most likely candidate for this GGTP elevation is the chronic consumption of alcohol. Underlying liver disease is a less likely possibility in view of the remarkable normality of other tests of liver function. Enzyme induction by anticonvulsant medications in the seizure-positive group is also unlikely, since these drug levels were undetectable in most cases.
At the time of readmission, laboratory parameters were remarkably normal both for the group with a seizure history and those without. In contrast to findings at the time of initial admission, at the time of readmission, both GGTP and MCV distinguished the group with seizures from those without. The elevated levels of MCV most likely reflect significant alcohol consumption rather than underlying organ pathology in view of the normal haematocrits in both groups. Likewise, the elevated GGTP is at least, in part, accounted for by chronic alcohol consumption, since ALT, albumin and bilirubin were normal for the majority of persons in each group. However, in view of the elevated AST in some of the subjects, it is also possible that underlying liver disease may account for this GGTP elevation. It is unclear whether the elevation of alkaline phosphatase represents a drug side-effect, recent bone trauma or underlying liver disease. In view of the elevation of the AST, the latter possibility is the most likely.
In conclusion, this study extends results of previous reports that there is a correlation between seizure occurrence and repeated detoxification. In this readmitted group, there was also a strong correlation between neurological admissions and seizure history. At the time of index admission, a wide spectrum of laboratory parameters was normal in both groups. At follow-up, laboratory markers of alcohol consumption were more commonly abnormal in the group with a history of seizures.
